Brief: Argent Biopharma Names Igor Bluvstein As CFO
07/05/2024 07:27
May 7 (Reuters) - Argent BioPharma Ltd RGT.AX :
* ARGENT BIOPHARMA LTD - TRADING ON THE OTCQB AND
APPOINTMENT OF
CFO
* ARGENT BIOPHARMA LTD: APPOINTMENT OF IGOR BLUVSTEIN AS
CHIEF
FINANCIAL OFFICER
Source text for Eikon: ID:nRSG3880Na
Further company coverage: RGT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group